Craig Adam R's Form 4 filing
Cti Biopharma Corp (CTIC) · filed Jun 3, 2022
- Accession no.
- 0000891293-22-000027
- Filed
- Jun 3, 2022
- Trade date
- Jun 1-3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $433.5K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000891293-22-000028 (Jun 3, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Craig Adam RCIK 0001339498 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | common stock | MOption exerciseAcquired | +27,000 | $0.84 | +$22,680 | 43,678 | Direct | |
| Jun 1, 2022 | common stock | SSaleDisposed | −27,000 | $6.00 | −$162,000 | 16,678 | Direct | |
| Jun 2, 2022 | common stock | MOption exerciseAcquired | +27,000 | $0.84 | +$22,680 | 43,678 | Direct | |
| Jun 2, 2022 | common stock | SSaleDisposed | −27,000 | $6.00 | −$162,000 | 16,678 | Direct | |
| Jun 3, 2022 | common stock | MOption exerciseAcquired | +18,223 | $0.84 | +$15,307.32 | 34,901 | Direct | |
| Jun 3, 2022 | common stock | SSaleDisposed | −18,223 | $6.01 | −$109,520.23 | 16,678 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | Common Stock | MOption exerciseDisposed | −27,000 | $0.00 | $0 | 1,273,000 | Direct | |
| Jun 2, 2022 | Common Stock | MOption exerciseDisposed | −27,000 | $0.00 | $0 | 1,246,000 | Direct | |
| Jun 3, 2022 | Common Stock | MOption exerciseDisposed | −18,223 | $0.00 | $0 | 1,227,777 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.